Eli Lilly to roll out diabetes medicine in prefilled pen

Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The KwikPen offers a convenient, once-weekly administration. It contains four fixed doses. This launch intensifies competition with Novo Nordisk's Wegovy. Mounjaro's dual mechanism may offer superior efficacy. The availability of all six dosage options will support personalized treatment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yKveCG0
via IFTTT